Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
Latreille J, Pater J, Johnston D, Laberge F, Stewart D, Rusthoven J, Hoskins P, Findlay B, McMurtrie E, Yelle L, Williams C, Walde D, Ernst S, Dhaliwal H, Warr D, Shepherd F, Mee D, Nishimura L, Osoba D, Zee B.
Latreille J, et al. Among authors: laberge f.
J Clin Oncol. 1998 Mar;16(3):1174-8. doi: 10.1200/JCO.1998.16.3.1174.
J Clin Oncol. 1998.
PMID: 9508205
Clinical Trial.